Organic and mutagenic impurities in pharma

The pursuit of high-quality active substances remains paramount in the pharmaceutical industry. A critical factor in achieving this goal is meticulous control of impurity content. Evaluating impurities in pharmaceuticals is essential to guarantee both their safety and efficacy.  These unintended molecules arise during synthesis, storage, or formulation, and some may harbor potential toxicity.